Search

everythinglearnresearchcommunity

for

Search:↓

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

AP-1 controls tumor cell type by affecting key signaling pathways.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requiring high doses of calcium and vitamin D for treatment.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requires high doses of calcium and vitamin D for management.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

A gene mutation causes a rare hereditary hair loss, offering potential for new treatments.

Researchers made a mouse model with curly hair and hair loss by editing a gene.

Monilethrix involves multiple genes affecting hair structure, including DSG4 mutations.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

A mutation in the human hairless gene causes alopecia universalis.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

A 2-year-old girl with a rare vitamin D disorder had rickets and hair loss, but treatment was ineffective due to poor compliance.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

A mutation in the KRT25 gene causes a rare hair disorder with thin, woolly hair.

A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.